Industry-leader in applying mechanistic modeling to drug R&D, providing quantitative and predictive guidance to accelerate, optimize, and de-risk your R&D.
Massachusetts
Joined February 2014
- Tweets428
- Following318
- Followers475
- Likes138
Applied BioMath is hiring a Technical Marketing Specialist appliedbiomath.applytojob.co… via @JazzDotCo
Congratulations Applied BioMath team on an insightful paper demonstrating that incorporating Early Feasibility Assessment into our discovery strategy team strategy helps all of us to achieve our goal of developing transformational…lnkd.in/d_v2jvuK lnkd.in/dgX6Gpt9
Officially published in the 2023 Pi Day edition of CPTPSP. Congratulations to the Novartis and Applied BioMath teams for a great piece of sciences. lnkd.in/ehXaa5tg
Top 10% of Frontiers papers! Hopefully this is inspiring a lot of teams to think about using modeling and simulation early in their drug discovery programs. Great work to the Applied BioMath Team who worked on this! lnkd.in/gqZqBiRh
Join us Thursday, September 15th, for our 5th annual QSP Summit. This is a free event that features talks from speakers at Astellas Pharma, EMD Serono Inc., Sanofi, and Xencor, as well as a poster session and networking time. Register at: hubs.li/Q01kM7FW0
Applied BioMath retweeted
In this GENcast we sat down with an expert in mechanistic modeling to discuss the specific of this approach and how companies are employing the technology successfully. Listen Now! — with @AppliedBioMath. Read more: ow.ly/gZzi50KnbAS
Call for abstracts! Poster prizes awarded to the top three trainee (student, graduate student, and postdoc) posters. Register or submit an abstract: hubs.li/Q01jSC6F0
Dr. Alison Betts is speaking in the webinar, "Minimum Anticipated Biological Effect Level (MABEL) for Selection of First-in-Human (FIH) Starting Dose of Immune-Activating Biotherapeutics," presented by the ASCPT Oncology Community today at 1pm. Register: hubs.li/Q01hGy1m0
Have questions about Applied BioMath Assess™ or interested in seeing a demo? Come to our virtual office hours held every Tuesday and Thursday at 12pm ET! Register here: hubs.li/Q01h0Nkw0
Applied BioMath retweeted
Applied BioMath Announces Collaboration with BYOMass for Systems Pharmacology Modeling in #Oncology
byomasstx.com/applied-biomat…
@AppliedBioMath #TGFβsuperfamily #biologics #smallmolecules #precisionmedicine #cancer #TGFbeta
John Burke, PhD, Co-Founder, President and CEO of Applied BioMath, is presenting at Bio-IT World Conference & Expo on Tuesday, September 21th, at 10:30 a.m. ET. Learn more about his presentation at: appliedbiomath.com/news-reso…
Pharma and Biotech R&D requires many incremental decisions with serious implications. We use a variety of mathematical approaches to help inform and de-risk decisions at every stage of R&D. Reach out to learn how we can support your team's decision-making! appliedbiomath.com/contact-u…
Jump start your biotherapeutics and learn how Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more at: hubs.li/H0Tr9V50
Learn how we collaborated with Alexion Pharmaceuticals to develop a QSP model which assesses a Lipid Nanoparticle to treat Crigler‐Najjar Syndrome Type 1 and to support translation from preclinical to clinical trials. View the webinar at: hubs.li/H0TmFk70
Did you know our services span throughout the entire drug R&D continuum from discovery through clinical research? Learn more about our services and how we can help your project team at: appliedbiomath.com/our-solut…
Learn how we collaborated with CSL Behring to develop a mathematical model for autologous stem cell therapy to cure sickle cell disease. View the publication at: hubs.li/H0RN-N40
We are excited to announce our collaboration with Ichnos Sciences! Check out our press release to learn how we are developing a systems pharmacology model for a bispecific antibody in oncology. Read the full press release at: hubs.li/H0Rf_6q0
Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more about our software and schedule a demo at: hubs.li/H0MPs9j0
Have you registered for our upcoming webinar? Tune in Thursday, April 29th, at 12pm and listen as John Burke, PhD, Co-Founder, President and CEO of Applied BioMath, explains how Applied BioMath Assess™ can help your project team. Register at: hubs.li/H0LD_ml0
Jump start your biotherapeutics and learn how Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more at: hubs.li/H0Ljs9n0
